TheEdgeResearch
Home / Stocks / DHR

Danaher Corporation (DHR)

NYSE Healthcare Medical - Diagnostics & Research
$178.23 ▲ +0.60%
Market Cap
$126.15B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.83
52-Wk Range
160.93-242.8
CEO
Rainer Blair
Country
US
Currency
USD

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, l…

Open full interactive analysis & DCF →